How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
about
Research priorities in sarcomeric cardiomyopathiesPerturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutationsReview of Journal of Cardiovascular Magnetic Resonance 2011.Review of journal of cardiovascular magnetic resonance 2010.The systolic paradox in hypertrophic cardiomyopathy.Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction.Assessment of regional left ventricular systolic function by strain imaging echocardiography in phenotypically normal and abnormal Maine coon cats tested for the A31P mutation in the MYBPC3 gene.ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease.Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.The development of familial hypertrophic cardiomyopathy: from mutation to bedside.The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals?Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association.Diastolic Dysfunction of Hypertrophic Cardiomyopathy Genotype-Positive Subjects Without Hypertrophy Is Detected by Tissue Doppler Imaging: A Systematic Review and Meta-Analysis.Life-long tailoring of management for patients with hypertrophic cardiomyopathy : Awareness and decision-making in changing scenarios.Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations.Diastolic abnormalities in normal phenotype hypertrophic cardiomyopathy gene carriers: a study using speckle tracking echocardiography.Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography.Comparison of local sine wave modeling with harmonic phase analysis for the assessment of myocardial strain.Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.
P2860
Q27694507-7E03E4E0-8B3A-43CD-838F-E7E70E552076Q28287468-500F444A-1D50-4C2E-A80C-D35780C1D383Q30459937-0DDBE172-3862-4AA6-8380-0FF151485EE5Q30474025-8AE47DA1-BD11-44DF-ABB0-AAEADB7E4A04Q33801809-369EAF02-7F14-4DE2-AD5D-BDF8FF9F310FQ34054904-95C56B74-187E-46D7-AA0D-3FB1D29383B0Q35893509-25479446-89CF-4AB8-B19F-AE2B3B5ED7C2Q36346538-EAED738B-6B64-45CD-8432-7D25DF4A4814Q36394188-6E6B93CF-0BB2-480F-A0DE-17A223E4CCC8Q36678501-7FBF40E4-C113-4907-B30A-D861BBBFCCD4Q37629210-29D5806C-06D6-45CD-AD38-46C62DFB1389Q37821051-19E1D065-B3B4-4263-9B11-FEC93730BB1DQ37822294-9586BE91-01B3-45DB-BFF5-C01EF7F8E560Q37983728-70C56B05-B242-4F76-BF4C-1358FFDC17D0Q38059853-71626727-C297-404C-BFEF-CB5E1F505508Q38343713-F4CD50D1-082F-488C-8469-01F1C6B7D741Q38740990-FE7A7506-9EF4-438F-865E-3A73E0EF34E9Q42320941-DCDD6320-E083-4466-894C-B1E6825E5DCEQ44354566-447D8008-A579-4E4D-A46B-9ED74949E07BQ45894311-75D06EE4-6748-4CF5-8C05-AB616A10634FQ48747083-23BFF622-A3B1-4398-A10D-F64315144CE5Q50518856-619A1FD1-263E-41B4-84F3-E3DFEF92648FQ53006905-413D7186-DAE5-4083-AFB8-4C25A011FD02Q53128583-825AD432-B56F-4363-8623-8500DDFFAA45Q53399558-94CB7C14-F6D2-40D0-A274-59D87337B06D
P2860
How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@ast
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@en
type
label
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@ast
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@en
prefLabel
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@ast
How do hypertrophic cardiomyop ...... iovascular magnetic resonance.
@en
P2093
P2860
P356
P1476
How do hypertrophic cardiomyop ...... diovascular magnetic resonance
@en
P2093
Albert C van Rossum
Arthur A M Wilde
Iris K Rüssel
Marco J W Götte
Marieke D Spreeuwenberg
Pieter A Doevendans
Tjeerd Germans
Yigal M Pinto
P2860
P2888
P356
10.1186/1532-429X-12-13
P577
2010-03-15T00:00:00Z
P6179
1039076084